-
Je něco špatně v tomto záznamu ?
Boldine enhances bile production in rats via osmotic and farnesoid X receptor dependent mechanisms
J. Cermanova, Z. Kadova, M. Zagorova, M. Hroch, P. Tomsik, P. Nachtigal, Z. Kudlackova, P. Pavek, M. Dubecka, M. Ceckova, F. Staud, T. Laho, S. Micuda,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
NT13473
MZ0
CEP - Centrální evidence projektů
- MeSH
- ABC transportéry nedostatek genetika metabolismus MeSH
- aplikace orální MeSH
- aporfiny aplikace a dávkování metabolismus farmakologie MeSH
- buňky Hep G2 MeSH
- buňky MDCK MeSH
- cholagoga a choleretika aplikace a dávkování metabolismus farmakologie MeSH
- ethinylestradiol farmakologie MeSH
- genetická transkripce účinky léků MeSH
- glutathion metabolismus MeSH
- hepatobiliární exkrece MeSH
- intravenózní infuze MeSH
- játra účinky léků metabolismus MeSH
- kinetika MeSH
- lidé MeSH
- osmóza MeSH
- potkani inbrední LEW MeSH
- potkani transgenní MeSH
- potkani Wistar MeSH
- proteiny spojené s mnohočetnou rezistencí k lékům genetika metabolismus MeSH
- psi MeSH
- receptory cytoplazmatické a nukleární agonisté genetika metabolismus MeSH
- signální transdukce účinky léků MeSH
- transfekce MeSH
- upregulace MeSH
- žluč metabolismus MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- psi MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Boldine, the major alkaloid from the Chilean Boldo tree, is used in traditional medicine to support bile production, but evidence to support this function is controversial. We analyzed the choleretic potential of boldine, including its molecular background. The acute- and long-term effects of boldine were evaluated in rats either during intravenous infusion or after 28-day oral treatment. Infusion of boldine instantly increased the bile flow 1.4-fold in healthy rats as well as in animals with Mrp2 deficiency or ethinylestradiol induced cholestasis. This effect was not associated with a corresponding increase in bile acid or glutathione biliary excretion, indicating that the effect is not related to stimulation of either bile acid dependent or independent mechanisms of bile formation and points to the osmotic activity of boldine itself. We subsequently analyzed bile production under conditions of changing biliary excretion of boldine after bolus intravenous administration and found strong correlations between both parameters. HPLC analysis showed that bile concentrations of boldine above 10 μM were required for induction of choleresis. Importantly, long-term pretreatment, when the bile collection study was performed 24-h after the last administration of boldine, also accelerated bile formation despite undetectable levels of the compound in bile. The effect paralleled upregulation of the Bsep transporter and increased biliary clearance of its substrates, bile acids. We consequently confirmed the ability of boldine to stimulate the Bsep transcriptional regulator, FXR receptor. In conclusion, our study clarified the mechanisms and circumstances surrounding the choleretic activity of boldine.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15031432
- 003
- CZ-PrNML
- 005
- 20170523103027.0
- 007
- ta
- 008
- 151005s2015 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.taap.2015.03.004 $2 doi
- 035 __
- $a (PubMed)25771127
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Cermanová, Jolana, $u Department of Pharmacology, Charles University in Prague, Faculty of Medicine in Hradec Kralove, Czech Republic. $d 1965- $7 xx0076211
- 245 10
- $a Boldine enhances bile production in rats via osmotic and farnesoid X receptor dependent mechanisms / $c J. Cermanova, Z. Kadova, M. Zagorova, M. Hroch, P. Tomsik, P. Nachtigal, Z. Kudlackova, P. Pavek, M. Dubecka, M. Ceckova, F. Staud, T. Laho, S. Micuda,
- 520 9_
- $a Boldine, the major alkaloid from the Chilean Boldo tree, is used in traditional medicine to support bile production, but evidence to support this function is controversial. We analyzed the choleretic potential of boldine, including its molecular background. The acute- and long-term effects of boldine were evaluated in rats either during intravenous infusion or after 28-day oral treatment. Infusion of boldine instantly increased the bile flow 1.4-fold in healthy rats as well as in animals with Mrp2 deficiency or ethinylestradiol induced cholestasis. This effect was not associated with a corresponding increase in bile acid or glutathione biliary excretion, indicating that the effect is not related to stimulation of either bile acid dependent or independent mechanisms of bile formation and points to the osmotic activity of boldine itself. We subsequently analyzed bile production under conditions of changing biliary excretion of boldine after bolus intravenous administration and found strong correlations between both parameters. HPLC analysis showed that bile concentrations of boldine above 10 μM were required for induction of choleresis. Importantly, long-term pretreatment, when the bile collection study was performed 24-h after the last administration of boldine, also accelerated bile formation despite undetectable levels of the compound in bile. The effect paralleled upregulation of the Bsep transporter and increased biliary clearance of its substrates, bile acids. We consequently confirmed the ability of boldine to stimulate the Bsep transcriptional regulator, FXR receptor. In conclusion, our study clarified the mechanisms and circumstances surrounding the choleretic activity of boldine.
- 650 _2
- $a ABC transportéry $x nedostatek $x genetika $x metabolismus $7 D018528
- 650 _2
- $a aplikace orální $7 D000284
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a aporfiny $x aplikace a dávkování $x metabolismus $x farmakologie $7 D001060
- 650 _2
- $a žluč $x metabolismus $7 D001646
- 650 _2
- $a cholagoga a choleretika $x aplikace a dávkování $x metabolismus $x farmakologie $7 D002756
- 650 _2
- $a psi $7 D004285
- 650 _2
- $a ethinylestradiol $x farmakologie $7 D004997
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a glutathion $x metabolismus $7 D005978
- 650 _2
- $a buňky Hep G2 $7 D056945
- 650 _2
- $a hepatobiliární exkrece $7 D065669
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a intravenózní infuze $7 D007262
- 650 _2
- $a kinetika $7 D007700
- 650 _2
- $a játra $x účinky léků $x metabolismus $7 D008099
- 650 _2
- $a buňky MDCK $7 D061985
- 650 _2
- $a proteiny spojené s mnohočetnou rezistencí k lékům $x genetika $x metabolismus $7 D027425
- 650 _2
- $a osmóza $7 D009995
- 650 _2
- $a potkani inbrední LEW $7 D011917
- 650 _2
- $a potkani transgenní $7 D055647
- 650 _2
- $a potkani Wistar $7 D017208
- 650 _2
- $a receptory cytoplazmatické a nukleární $x agonisté $x genetika $x metabolismus $7 D018160
- 650 _2
- $a signální transdukce $x účinky léků $7 D015398
- 650 _2
- $a genetická transkripce $x účinky léků $7 D014158
- 650 _2
- $a transfekce $7 D014162
- 650 _2
- $a upregulace $7 D015854
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Kadová, Zuzana $u Department of Pharmacology, Charles University in Prague, Faculty of Medicine in Hradec Kralove, Czech Republic; Deparment of Pharmacology and Toxicology, Charles University in Prague, Faculty of Pharmacy in Hradec Kralove, Czech Republic. $7 xx0213787
- 700 1_
- $a Zagorova, Marie $u Department of Pharmacology, Charles University in Prague, Faculty of Medicine in Hradec Kralove, Czech Republic.
- 700 1_
- $a Hroch, Miloš, $u Department of Pharmacology, Charles University in Prague, Faculty of Medicine in Hradec Kralove, Czech Republic; Department of Medical Biochemistry, Charles University in Prague, Faculty of Medicine in Hradec Kralove, Czech Republic. $d 1976- $7 xx0076212
- 700 1_
- $a Tomšík, Pavel, $u Department of Medical Biochemistry, Charles University in Prague, Faculty of Medicine in Hradec Kralove, Czech Republic. $d 1977- $7 xx0076495
- 700 1_
- $a Nachtigal, Petr $u Department of Biological and Medical Sciences, Charles University in Prague, Faculty of Pharmacy in Hradec Kralove, Czech Republic. $7 uk2009304471
- 700 1_
- $a Kudláčková, Zdeňka, $u Department of Biological and Medical Sciences, Charles University in Prague, Faculty of Pharmacy in Hradec Kralove, Czech Republic. $d 1968- $7 xx0001985
- 700 1_
- $a Pávek, Petr $u Deparment of Pharmacology and Toxicology, Charles University in Prague, Faculty of Pharmacy in Hradec Kralove, Czech Republic. $7 xx0093070
- 700 1_
- $a Dubecka, Michaela $u Deparment of Pharmacology and Toxicology, Charles University in Prague, Faculty of Pharmacy in Hradec Kralove, Czech Republic.
- 700 1_
- $a Čečková, Martina $u Deparment of Pharmacology and Toxicology, Charles University in Prague, Faculty of Pharmacy in Hradec Kralove, Czech Republic. $7 xx0049092
- 700 1_
- $a Štaud, František, $u Deparment of Pharmacology and Toxicology, Charles University in Prague, Faculty of Pharmacy in Hradec Kralove, Czech Republic. $d 1970- $7 stk2007393932
- 700 1_
- $a Laho, Tomas $u Department of Pharmacology, Charles University in Prague, Faculty of Medicine in Hradec Kralove, Czech Republic.
- 700 1_
- $a Mičuda, Stanislav, $u Department of Pharmacology, Charles University in Prague, Faculty of Medicine in Hradec Kralove, Czech Republic. Electronic address: micuda@lfhk.cuni.cz. $d 1972- $7 jn20010309083
- 773 0_
- $w MED00010691 $t Toxicology and applied pharmacology $x 1096-0333 $g Roč. 285, č. 1 (2015), s. 12-22
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25771127 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20151005 $b ABA008
- 991 __
- $a 20170523103423 $b ABA008
- 999 __
- $a ok $b bmc $g 1092308 $s 914558
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 285 $c 1 $d 12-22 $e 20150312 $i 1096-0333 $m Toxicology and applied pharmacology $n Toxicol Appl Pharmacol $x MED00010691
- GRA __
- $a NT13473 $p MZ0
- LZP __
- $a Pubmed-20151005
